Synthesis and N-Methyl-D-aspartate (NMDA) Receptor Activity of Ketamine Metabolites

被引：67

作者：

Morris, Patrick J. ^{[1
]}

Moaddel, Ruin ^{[2
]}

Zanos, Panos ^{[3
]}

Moore, Curtis E. ^{[4
]}

Gould, Todd ^{[3
,5
,6
]}

Zarate, Carlos A., Jr. ^{[7
]}

Thomas, Craig J. ^{[1
]}

机构：

[1] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA

[2] NIA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA

[3] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA

[4] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA

[5] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA

[6] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA

[7] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, Bethesda, MD 20892 USA

来源：

ORGANIC LETTERS | 2017年 / 19卷 / 17期

关键词：

ANTIDEPRESSANT; MECHANISMS; DEPRESSION; AMINATION; CURRENTS; PLASMA;

D O I：

10.1021/acs.orglett.7b02177

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Ketamine is rapidly metabolized in the human body to a variety of metabolites, including the hydroxynorketamines. At least two hydroxynorketamines have significant antidepressant action in rodent models, with limited action against the N-methyl-D-aspartate (NMDA) receptor. The synthesis of 12 hydroxynorketamines and their binding affinity to the NMDA receptor is presented here.

引用

页码：4572 / 4575

页数：4

共 23 条

[1]

Berman F W, 1996, J Biochem Toxicol, V11, P217, DOI 10.1002/(SICI)1522-7146(1996)11:5<217::AID-JBT2>3.0.CO

[2]

2-N

[3] Asymmetric synthesis of (S)- and (R)-norketamine via Sharpless asymmetric dihydroxylation/Ritter amination sequence [J].

Biermann, Manfred ;

Zheng, Guangrong ;

Hojahmat, Marhaba ;

Moskalev, Nick V. ;

Crooks, Peter A. .

TETRAHEDRON LETTERS, 2015, 56 (20) :2608-2610

[4] The use of ketamine as an antidepressant: a systematic review and meta-analysis [J].

Coyle, Caoimhe M. ;

Laws, Keith R. .

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2015, 30 (03) :152-163

[5] Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs [J].

Dale, Elena ;

Bang-Andersen, Benny ;

Sanchez, Connie .

BIOCHEMICAL PHARMACOLOGY, 2015, 95 (02) :81-97

[6] MOLECULAR DESIGN OF THE N-METHYL-D-ASPARTATE RECEPTOR-BINDING SITE FOR PHENCYCLIDINE AND DIZOLCIPINE [J].

FERRERMONTIEL, AV ;

SUN, W ;

MONTAL, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :8021-8025

[7] STEREOCHEMICAL STUDIES OF DEMETHYLATED KETAMINE ENANTIOMERS [J].

HONG, SC ;

DAVISSON, JN .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (08) :912-914

[8] COMPARATIVE PHARMACOLOGY IN THE RAT OF KETAMINE AND ITS 2 PRINCIPAL METABOLITES, NORKETAMINE AND (Z)-6-HYDROXYNORKETAMINE [J].

LEUNG, LY ;

BAILLIE, TA .

JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (11) :2396-2399

[9] Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors [J].

Moaddel, Ruin ;

Abdrakhmanova, Galia ;

Kozak, Joanna ;

Jozwiak, Krzysztof ;

Toll, Lawrence ;

Jimenez, Lucita ;

Rosenberg, Avraham ;

Tran, Thao ;

Xiao, Yingxian ;

Zarate, Carlos A. ;

Wainer, Irving W. .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 698 (1-3) :228-234

[10] A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome [J].

Moaddel, Ruin ;

Venkata, Swarajya Lakshmi Vattem ;

Tanga, Mary J. ;

Bupp, James E. ;

Green, Carol E. ;

Iyer, Lalitha ;

Furimsky, Anna ;

Goldberg, Michael E. ;

Torjman, Marc C. ;

Wainer, Irving W. .

TALANTA, 2010, 82 (05) :1892-1904

← 1 2 3 →